Antiviral Prophylaxis
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults (NCT03473002) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-05-16 |
Track Antiviral Prophylaxis automatically
Every clearance here is in the API, with alerts when new ones post.